Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HACD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TFDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WDR76 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM120A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KPNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TM7SF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRP36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAWR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMKMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TESMIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERFE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on